• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

Recent Advances in the Study of 1-(2,3-Dimethylphenyl)ethanol (CAS: 60907-90-6) in Chemical Biology and Pharmaceutical Research

1-(2,3-Dimethylphenyl)ethanol (CAS: 60907-90-6) is a chiral aromatic alcohol that has garnered significant attention in recent years due to its potential applications in pharmaceutical synthesis and chemical biology. This compound serves as a key intermediate in the production of various bioactive molecules, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents. Recent studies have focused on optimizing its synthesis, exploring its biological activities, and investigating its role in drug development.

One of the most notable advancements in the synthesis of 1-(2,3-Dimethylphenyl)ethanol involves the use of asymmetric hydrogenation techniques. Researchers have developed highly efficient catalytic systems, such as chiral ruthenium complexes, to achieve enantioselective reduction of the corresponding ketone precursor. These methods not only improve the yield and enantiomeric purity of the product but also align with the growing demand for sustainable and green chemistry practices in pharmaceutical manufacturing.

In addition to its synthetic utility, 1-(2,3-Dimethylphenyl)ethanol has been investigated for its potential biological activities. Preliminary in vitro studies suggest that this compound exhibits moderate anti-inflammatory and analgesic properties, possibly due to its structural similarity to known NSAIDs like ibuprofen and naproxen. Further research is underway to elucidate its mechanism of action and evaluate its efficacy in animal models of inflammation and pain.

The pharmacokinetic profile of 1-(2,3-Dimethylphenyl)ethanol has also been a subject of recent investigation. Studies using advanced analytical techniques, such as liquid chromatography-mass spectrometry (LC-MS), have provided insights into its metabolic pathways and bioavailability. These findings are critical for understanding how the compound behaves in vivo and for guiding the design of future derivatives with improved therapeutic properties.

Another promising area of research involves the incorporation of 1-(2,3-Dimethylphenyl)ethanol into more complex molecular architectures. For example, it has been used as a building block in the synthesis of novel drug candidates targeting G protein-coupled receptors (GPCRs) and enzymes involved in inflammatory pathways. The versatility of this compound makes it a valuable tool for medicinal chemists seeking to develop new treatments for a wide range of diseases.

Despite these advancements, challenges remain in the large-scale production and clinical application of 1-(2,3-Dimethylphenyl)ethanol. Issues such as cost-effective synthesis, scalability, and potential toxicity need to be addressed through further research. Collaborative efforts between academia and industry will be essential to overcome these hurdles and fully realize the potential of this compound in drug development.

In conclusion, 1-(2,3-Dimethylphenyl)ethanol (CAS: 60907-90-6) represents a versatile and promising compound in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its synthetic utility, biological activities, and potential therapeutic applications. Continued exploration of this molecule is expected to yield valuable insights and contribute to the development of new and improved pharmaceutical agents.

• 5472-13-9(2-Methylbenzhydrol)
• 5379-19-1(1-(2,4-dimethylphenyl)ethan-1-ol)
• 32917-52-5(1-(2,5-Dimethylphenyl)ethanol)
• 7287-82-3(1-(2-Methylphenyl)ethanol)
• 767-90-8((2-Ethylphenyl)methanol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)